ecc 2015: meteor trial showed cabozantinib improved survival in advanced kidney cancer
Published 8 years ago • 567 plays • Length 5:55Download video MP4
Download video MP3
Similar videos
-
5:49
cabozantinib improves advanced kidney cancer survival: meteor trial results
-
3:48
ecc 2015: checkmate 025 trial showed nivolumab improved overall survival in advanced kidney cancer
-
5:42
meteor trial: cabozantinib vs everolimus in advanced renal cell carcinoma
-
3:26
nivolumab and cabozantinib versus standard of care in renal cell carcinoma
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
6:30
cabozantinib: the meteor trial
-
4:09
subgroup analyses of meteor; randomized phase iii trial of cabozantinib vs everolimus for rcc
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
2:12
cabozantinib improves pfs in metastatic renal cell carcinoma
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
2:27
changing the standard of care in previously treated metastatic renal cell carcinoma
-
0:49
new kidney cancer rx outperformed standard treatment
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
7:29
results from cabosun, meteor and javelin
-
2:12
comment: new immunotherapy options for kidney cancer
-
2:38
cabozantinib for late stage kidney cancer
-
0:23
kidney cancer trial (the radical study)
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc